PubRank

Hiroaki Kume

Author PubWeight™ 28.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Am J Respir Cell Mol Biol 2006 1.07
2 A novel Ca2+ influx pathway activated by mechanical stretch in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2007 1.04
3 Actin cytoskeleton regulates stretch-activated Ca2+ influx in human pulmonary microvascular endothelial cells. Am J Respir Cell Mol Biol 2009 1.01
4 Mechanical stretch enhances IL-8 production in pulmonary microvascular endothelial cells. Biochem Biophys Res Commun 2009 1.01
5 Regulation of capacitative and noncapacitative receptor-operated Ca2+ entry by rho-kinase in tracheal smooth muscle. Am J Respir Cell Mol Biol 2002 0.93
6 The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J Immunol 2004 0.90
7 Viscoelastic and dynamic nonlinear properties of airway smooth muscle tissue: roles of mechanical force and the cytoskeleton. Am J Physiol Lung Cell Mol Physiol 2006 0.90
8 Interstitial lung disease associated with gefitinib. Respir Med 2005 0.87
9 Regulation of endothelin-1-induced interleukin-6 production by Ca2+ influx in human airway smooth muscle cells. Eur J Pharmacol 2009 0.87
10 Inhibition by the cold receptor agonists menthol and icilin of airway smooth muscle contraction. Pulm Pharmacol Ther 2008 0.87
11 Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery. Lung Cancer 2005 0.87
12 Roles of stretch-activated cation channel and Rho-kinase in the spontaneous contraction of airway smooth muscle. Eur J Pharmacol 2006 0.86
13 Apical and basolateral ATP-induced anion secretion in polarized human airway epithelia. Am J Respir Cell Mol Biol 2003 0.86
14 Essential role of GATA transcriptional factors in the activation of mast cells. J Immunol 2007 0.86
15 Effects of fluoranthene, a polycyclic aromatic hydrocarbon, on cAMP-dependent anion secretion in human airway epithelia. J Pharmacol Exp Ther 2003 0.86
16 Reduction of airway anion secretion via CFTR in sphingomyelin pathway. Biochem Biophys Res Commun 2004 0.85
17 Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Cancer Detect Prev 2004 0.85
18 Ion transport regulated by protease-activated receptor 2 in human airway Calu-3 epithelia. Br J Pharmacol 2005 0.83
19 Role of lysophosphatidylcholine in eosinophil infiltration and resistance in airways. Clin Exp Pharmacol Physiol 2004 0.83
20 ML-9, a myosin light chain kinase inhibitor, reduces intracellular Ca2+ concentration in guinea pig trachealis. Eur J Pharmacol 2004 0.83
21 Mediastinal fibrosis and positive antineutrophil cytoplasmic antibodies: coincidence or common etiology? Intern Med 2014 0.82
22 Direct effects of hydrogen peroxide on airway smooth muscle tone: roles of Ca2+ influx and Rho-kinase. Eur J Pharmacol 2006 0.82
23 Activation of the prefrontal cortex is associated with exertional dyspnea in chronic obstructive pulmonary disease. Respiration 2011 0.82
24 Thalidomide attenuates airway hyperresponsiveness and eosinophilic inflammation in a murine model of allergic asthma. Biol Pharm Bull 2010 0.82
25 Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia. Respir Med 2013 0.81
26 ATP release triggered by activation of the Ca2+-activated K+ channel in human airway Calu-3 cells. Am J Respir Cell Mol Biol 2003 0.81
27 Regulation of adenosine 5'-triphosphate (ATP)-gated P2X(4) receptors on tracheal smooth muscle cells. Respir Physiol Neurobiol 2009 0.80
28 Paradoxical effects of hydrogen peroxide on human airway anion secretion. J Pharmacol Exp Ther 2006 0.79
29 Possible Involvement of Sphingosine-1-Phosphate/G(i)/RhoA pathways in adherence of eosinophils to pulmonary endothelium. Allergol Int 2012 0.77
30 Bisphenol A inhibits Cl(-) secretion by inhibition of basolateral K+ conductance in human airway epithelial cells. J Pharmacol Exp Ther 2002 0.77
31 Role of Ca(2+) mobilization in desensitization of beta-adrenoceptors by platelet-derived growth factor in airway smooth muscle. Eur J Pharmacol 2008 0.77
32 Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma. Clin Exp Pharmacol Physiol 2006 0.76
33 [Evaluation of the symptoms, adherence and satisfaction after pharmaceutical care at asthma clinic for outpatient]. Yakugaku Zasshi 2011 0.76
34 Asthma health status: influence of disease severity categorized by peak expiratory flow. J Asthma 2003 0.75
35 Role of sphingosine-1-phosphate inβ-adrenoceptor desensitization via Ca(2+) sensitization in airway smooth muscle. Allergol Int 2012 0.75
36 Dual pathway activated by tert-butyl hydroperoxide in human airway anion secretion. J Pharmacol Exp Ther 2008 0.75
37 Cavitary pulmonary cryptococcosis with an Aspergillus fungus ball. Intern Med 2014 0.75
38 [Role of bronchodilators in therapy for COPD-mechanisms of LABA and LAMA on airway smooth muscle]. Nihon Rinsho 2016 0.75
39 [Drug allergy]. Nihon Rinsho 2002 0.75
40 Effects of inhaled aminophylline on airway constriction and inflammation in ovalbumin-sensitized guinea pigs. Drug Deliv 2013 0.75
41 Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer. Lung 2006 0.75
42 Effects of direct and indirect activation of G protein of adenylyl cyclase on the subsequent response to beta-adrenergic receptor agonists in human trachealis. Arzneimittelforschung 2002 0.75
43 Bioelectric toxicity caused by chlorpromazine in human lung epithelial cells. Toxicol Appl Pharmacol 2002 0.75
44 Different effects of beta-adrenoceptor desensitization on inhibitory actions in guinea-pig trachealis. Clin Exp Pharmacol Physiol 2002 0.75
45 [A case of Q fever infection causing acute exacerbation of chronic respiratory failure]. Nihon Kokyuki Gakkai Zasshi 2004 0.75
46 Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study. Lung Cancer 2010 0.75